Clinical Trials Directory

Trials / Completed

CompletedNCT00914121

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

A Single Dose, Crossover, Placebo- and Moxifloxacin- Controlled Study of the Effects of Bosutinib on Cardiac Repolarization in Healthy Adult Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the effect of SKI-606 on rhythms of the heart (cardiac repolarization)

Conditions

Interventions

TypeNameDescription
DRUGSKI-606
DRUGPlacebo
DRUGMoxifloxacin

Timeline

Start date
2009-06-01
Primary completion
2009-08-01
Completion
2009-08-01
First posted
2009-06-04
Last updated
2009-09-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00914121. Inclusion in this directory is not an endorsement.

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart) (NCT00914121) · Clinical Trials Directory